tradingkey.logo
tradingkey.logo
Search

Rigel Announces Publication Of Final Arrow Clinical Trial Data On Gavreto® (Pralsetinib)

ReutersMar 31, 2026 12:10 PM

- Rigel Pharmaceuticals Inc RIGL.O:

  • RIGEL ANNOUNCES PUBLICATION OF FINAL ARROW CLINICAL TRIAL DATA ON GAVRETO® (PRALSETINIB) IN PATIENTS WITH RET+ NSCLC IN THE JOURNAL OF CLINICAL ONCOLOGY

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI